Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, Quote & AI Analysis
Live ALNY stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Alnylam Pharmaceuticals, Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Alnylam Pharmaceuticals, Inc. (ALNY), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Alnylam Pharmaceuticals, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Alnylam Pharmaceuticals, Inc. Overview
Company information
Company Overview
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Alnylam Pharmaceuticals, Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...